Sign in
8-K

Current Report

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-007371

Material agreement · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading cns_8k.htm…